🇺🇸 Amlodipine + Perindopril in United States

203 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 203

Most-reported reactions

1. Drug Interaction — 40 reports (19.7%)
2. Hypotension — 23 reports (11.33%)
3. Toxicity To Various Agents — 20 reports (9.85%)
4. Cough — 19 reports (9.36%)
5. Oedema Peripheral — 18 reports (8.87%)
6. Off Label Use — 18 reports (8.87%)
7. Nausea — 17 reports (8.37%)
8. Cardiac Failure — 16 reports (7.88%)
9. Dyspnoea — 16 reports (7.88%)
10. Lactic Acidosis — 16 reports (7.88%)

Source database →

Frequently asked questions

Is Amlodipine + Perindopril approved in United States?

Amlodipine + Perindopril does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Amlodipine + Perindopril in United States?

Centre for Chronic Disease Control, India is the originator. The local marketing authorisation holder may differ — check the official source linked above.